Previous 10 | Next 10 |
Zimmer Biomet Announces Leadership Transition PR Newswire Chief Operating Officer Ivan Tornos Appointed President and CEO; Elected to the Board of Directors Chief Financial Officer Suketu (Suky) Upadhyay's Role Expands to CFO and EVP, Finance, Operations ...
2023-08-12 05:20:20 ET Summary Zimmer Biomet Holdings, Inc. has experienced a selloff alongside the healthcare sector in H2 FY'23. Despite the recent downturn, the company still represents compelling long-term value in my view. The company's Q2 numbers show growth in product r...
2023-08-11 18:56:58 ET Summary Health Care sector ETF (XLV) has underperformed the S&P 500 by 15 percentage points but has shown a modest revival in the last month. Zimmer Biomet had a solid earnings report and raised its 2023 revenue and earnings guidance, indicating potentia...
2023-08-09 17:58:16 ET Summary Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may b...
2023-08-09 02:50:00 ET Summary While U.S. equities extended their rally, Morningstar’s Moat Index extended its year-to-date lead over the S&P 500 to nearly 800 basis points. U.S. Bancorp stood out as the top contributor. U.S. equity markets continued their rally in July...
2023-08-01 13:12:07 ET Zimmer Biomet Holdings, Inc. (ZBH) Q2 2023 Earnings Conference Call August 01, 2023, 08:30 ET Company Participants Keri Mattox - SVP and Chief Communications & Administration Officer Bryan Hanson - Chairman, President & CEO Suketu U...
2023-08-01 06:38:01 ET Zimmer Biomet press release ( NYSE: ZBH ): Q2 Non-GAAP EPS of $1.82 beats by $0.01 . Revenue of $1.87B (+5.1% Y/Y) beats by $40M and 6.0% on a constant currency basis. Company raises 2023 financial guidance: 2023 Reported Revenue Cha...
Zimmer Biomet Announces Second Quarter 2023 Financial Results PR Newswire Second quarter net sales of $1.870 billion increased 4.9% and 6.0% on a constant currency 1 basis Second quarter diluted earnings per share were $1.00 ; adjusted 1 diluted earnings pe...
2023-07-31 13:05:55 ET Zimmer Biomet ( NYSE: ZBH ) is scheduled to announce Q2 earnings results on Tuesday, August 1st, before market open. The consensus EPS Estimate is $1.81 (-0.5% Y/Y) and the consensus Revenue Estimate is $1.83B (+2.8% Y/Y). Over the last 2 years, ...
2023-07-23 12:00:31 ET Soon after Johnson & Johnson ( NYSE: JNJ ) topped expectations with its Q2 2023 results last week, Baird came up with a report indicating brighter days for MedTech, mainly due to accelerating medical procedure volumes and a waning COVID impact in China. ...
News, Short Squeeze, Breakout and More Instantly...
Zimmer Biomet Holdings Inc. Company Name:
ZBH Stock Symbol:
NYSE Market:
Zimmer Biomet Holdings Inc. Website:
2024-07-15 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results PR Newswire WARSAW, Ind. , July 8, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will ...
Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors PR Newswire WARSAW, Ind. , June 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdika...